ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access®

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

July 10, 2023

Study Completion Date

July 10, 2023

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

Neurothrombectomy

"The ANA 5F device is intended to be inserted, be navigated to the neurovascular anatomy inside an outer catheter and be used as a conduit for insertion and guidance of intravascular catheters and retrieval devices into a selected blood vessel. The funnel is deployed by retracting the conduit catheter and is intended, when deployed, to provide temporary vascular flow restriction.~The device is indicated for the introduction of interventional devices into the neuro vasculature, during interventions for restoring blood flow in patients experiencing acute ischemic stroke due to large vessel occlusion."

Trial Locations (3)

Unknown

Hospital Universitari de la Vall d'Hebron, Barcelona

Hospital Universitari Dr. Josep Trueta, Girona

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia

Sponsors
All Listed Sponsors
lead

Anaconda Biomed S.L.

INDUSTRY

NCT05409430 - ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access® | Biotech Hunter | Biotech Hunter